CSTL FY 2018 Earnings — Castle Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

CSTLCastle Biosciences, Inc.

$772M

FY 2018 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$23M+65.7% YoY

Gross Profit

$17M76.8% margin

Operating Income

-$4M-16.8% margin

Net Income

-$6M-27.9% margin

EPS (Diluted)

$-0.60

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$13M

Stock-Based Comp.

$293,639

Balance Sheet

Total Assets

$22M

Total Liabilities

$32M

Stockholders' Equity

-$10M

Cash & Equivalents

$4M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$23M	$14M	+65.7%
Gross Profit	$17M	$9M	+98.0%
Operating Income	-$4M	-$11M	+64.8%
Net Income	-$6M	-$12M	+48.5%